Home › Research › Cognitive tests and assessment
Neuropsychiatric and Cognitive Symptoms Across the Alzheimer Disease Clinical Spectrum: Cross-sectional and Longitudinal Associations
Eikelboom WS, van den Berg E, Singleton EH, Baart SJ, Coesmans M, Leeuwis AE, Teunissen CE, van Berckel BNM et al.. Neurology, 2021-08-19
Topic: Amyloid, tau and blood-test diagnosis
Plain-language summary
Background and objectives To investigate the prevalence and trajectories of neuropsychiatric symptoms (NPS) in relation to cognitive functioning in a cohort of β-amyloid-positive (A+) individuals across the Alzheimer disease (AD) clinical spectrum. Methods In this single-center observational study, we included all individuals who visited the Alzheimer Center Amsterdam and had a clinical diagnosis of subjective cognitive decline (SCD), mild cognitive impairment (MCI), or probable AD dementia and were A+. We measured NPS with the Neuropsychiatric Inventory (NPI), examining total scores and the presence of specific NPI domains.
What this study adds
Evidence grade: Moderate
This is a follow-up (cohort) study of 520 participants. This single-centre observational study looked at how neuropsychiatric symptoms relate to cognitive functioning in people who were β-amyloid-positive across the Alzheimer's disease clinical spectrum. Reported effect size: 81.4%; 81.2%; 88.7%.
Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Eikelboom, W. S., van den Berg, E., Singleton, E. H., Baart, S. J., Coesmans, M., Leeuwis, A. E., et al. (2021). Neuropsychiatric and Cognitive Symptoms Across the Alzheimer Disease Clinical Spectrum: Cross-sectional and Longitudinal Associations. Neurology. https://doi.org/10.1212/wnl.0000000000012598
Vancouver
Eikelboom WS, van den Berg E, Singleton EH, Baart SJ, Coesmans M, Leeuwis AE, et al. Neuropsychiatric and Cognitive Symptoms Across the Alzheimer Disease Clinical Spectrum: Cross-sectional and Longitudinal Associations. Neurology. 2021. doi:10.1212/wnl.0000000000012598. PMID: 34413181.
BibTeX
@article{eikelboom2021-34413181,
author = {Eikelboom, W. S. and van den Berg, E. and Singleton, E. H. and Baart, S. J. and Coesmans, M. and Leeuwis, A. E. and Teunissen, C. E. and van Berckel, B. N. M. and others},
title = {{Neuropsychiatric and Cognitive Symptoms Across the Alzheimer Disease Clinical Spectrum: Cross-sectional and Longitudinal Associations}},
journal = {Neurology},
year = {2021},
doi = {10.1212/wnl.0000000000012598},
pmid = {34413181},
url = {https://doi.org/10.1212/wnl.0000000000012598}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record's author list ends in “et al.”, so not every author is named. Check the citation against the original before you use it.
Key findings
- Methods In this single-center observational study, we included all individuals who visited the Alzheimer Center Amsterdam and had a clinical diagnosis of subjective cognitive decline (SCD), mild cognitive impairment (MCI), or probable AD dementia and were A+.
- We measured NPS with the Neuropsychiatric Inventory (NPI), examining total scores and the presence of specific NPI domains.
- Cognition was assessed across 5 cognitive domains and with the Mini-Mental State Examination (MMSE).
- We examined trajectories including model-based trends for NPS and cognitive functioning over time.
Why it matters
This single-centre observational study looked at how neuropsychiatric symptoms relate to cognitive functioning in people who were β-amyloid-positive across the Alzheimer's disease clinical spectrum. It describes associations over time and does not test any treatment, cure or prevention.
Study details
- Study designlongitudinal study
- Participants520
- Effect size81.4%; 81.2%; 88.7%
- Evidence strengthModerate
How this study scored 69/100
Published in a leading specialty journal, and it is a longitudinal study following the same people over time. Scored zero for randomized / blinded because the record does not state it.
| Component | Points | Why |
|---|---|---|
| Journal tier | 9 / 10 | Tier 2 — leading specialty journal (Neurology) |
| Journal's citation record | 4 / 4 | Neurology: journal h-index 525 (OpenAlex, 2026-10-29) |
| Study design | 7 / 12 | A longitudinal study following the same people over time |
| Strength of evidence | 3 / 5 | Rated “moderate” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 3 / 5 | 2021 — within 6 year(s) of the newest study here |
| Sample size | 2 / 4 | 520 participants |
| Effect reported | 2 / 3 | Effect reported as a number, without an interval or test |
| Studied in people | 3 / 3 | Studied in people (participant count stated) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | 5 / 7 | Cited 122 times (OpenAlex, 2026-10-10) |
| Citations per year | 3 / 5 | 17.4 citations a year over 7 year(s) since 2021 |
| Impact for its field and year | 4 / 6 | Cited 12.4× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 2 / 6 | Cited by 5 other studies in this library |
| Still being cited | 3 / 4 | Cited 82 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | 2 / 4 | Last-listed author Janne M. Papma: h-index 40 (OpenAlex, whole career) |
| Institution's track record | 1 / 3 | Erasmus MC: institution h-index 1,321 (OpenAlex) |
| Multicenter collaboration | 2 / 3 | OpenAlex lists 5 institution(s) in 2 countries |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 34413181) |
| Free to read | 2 / 2 | Free to read |
| Total | 69 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).
Related
Studies in the library that share something with this one. The line above each title says what.
Studies this one cites
Referenced by this study and also in the alzhub library, so you can read them here. Showing 12 of 14.
Later studies that cite this one
5 studies in the alzhub library list this one in their references.
Related studies in Cognitive tests and assessment from nearby years
Also in Cognitive tests and assessment
100 studies in the library are filed under Cognitive tests and assessment with no topic tag they share with another; these are this study's neighbours in a fixed tour of them. The Cognitive tests and assessment hub.